Published in Bull World Health Organ on January 01, 1976
Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J (2010) 2.47
The changing limits and incidence of malaria in Africa: 1939-2009. Adv Parasitol (2012) 1.72
Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands. BMC Infect Dis (2012) 1.07
Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 2. The impact of chloroquine used as a chemosuppressant on the immune status of the population. Bull World Health Organ (1982) 1.05
Estimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models. Malar J (2016) 0.80
[Seroepidemiological study of malaria in the Algerian Sahara]. Bull World Health Organ (1991) 0.75
The use of thick-smear antigen slides in the malaria indirect fluorescent antibody test. J Parasitol (1967) 2.40
A research standard for human serum immunoglobulins IgG, IgA and IgM. Bull World Health Organ (1970) 7.25
A simple epidemiological model for evaluating the malaria inoculation rate and the risk of infection in infants. Bull World Health Organ (1974) 3.93
A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Bull World Health Organ (1983) 3.31
An international reference preparation for human serum immunoglobulins G, A and M: content of immunoglobulins by weight. Bull World Health Organ (1972) 2.82
Epidemiological model of typhoid fever and its use in the planning and evaluation of antityphoid immunization and sanitation programmes. Bull World Health Organ (1971) 2.77
Necropsy or autopsy? It's all about communication! Vet Pathol (2011) 2.59
Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J Clin Microbiol (1983) 2.34
Dispersion studies of Culex pipiens fatigans tagged with 32P in the Kemmendine area of Rangoon, Burma. Bull World Health Organ (1967) 2.31
Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol (1994) 2.29
Some factors affecting cyclopropane acid formation in Escherichia coli. Biochem J (1965) 2.21
Indicators for the forecasting of malaria epidemics. Bull World Health Organ (1980) 2.15
An extracellular lipopolysaccharide-phospholipid-protein complex produced by Escherichia coli grown under lysine-limiting conditions. Biochem J (1967) 2.10
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol (2001) 1.98
Vision screening for frail older people: a randomised trial. Br J Ophthalmol (2008) 1.93
Malaria epidemiology in the province of Moyen Ogoov, Gabon. Trop Med Parasitol (1995) 1.85
Simple method for rough determination of the cost-benefit balance point of immunization programmes. Bull World Health Organ (1971) 1.79
Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux). Diagn Microbiol Infect Dis (1998) 1.78
A clinical audit of patients on an orthopaedic waiting list for greater than two years. N Z Med J (1992) 1.76
Impact of control measures on malaria transmission and general mortality. Bull World Health Organ (1976) 1.72
High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg (1996) 1.71
High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. Am J Trop Med Hyg (1993) 1.70
Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol (1999) 1.61
Field evaluation of drug resistance in malaria. In vitro micro-test. Acta Trop (1980) 1.61
Emerging pathogens. Med Mycol (2000) 1.59
Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 1. Results of in vivo and in vitro studies and of an ophthalmological survey. Bull World Health Organ (1982) 1.56
Immunological diagnosis of human filariases: present possibilities, difficulties and limitations. Acta Trop (1974) 1.53
In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand. Bull World Health Organ (1999) 1.52
Lamivudine therapy of WHV-infected woodchucks. Virology (1998) 1.52
The transmission potential of monkeypox virus in human populations. Int J Epidemiol (1988) 1.50
Intestinal structure and function after small bowel by-pass in the rat. Clin Sci (1972) 1.47
Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J (1989) 1.45
A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria. Bull World Health Organ (1985) 1.43
Urgent efforts needed to combat drug-resistant malaria. WHO Chron (1983) 1.42
Use of simulated blood cultures to compare a specific fungal medium with a standard microorganism medium for yeast detection. Eur J Clin Microbiol Infect Dis (1998) 1.41
Sensitivity and specificity of the neonatal brain-stem auditory evoked potential for hearing and language deficits in survivors of extracorporeal membrane oxygenation. J Pediatr (1997) 1.40
A septate polycarbonate cell culture unit used for Plasmodium falciparum and hybridomas. Trans R Soc Trop Med Hyg (1988) 1.40
The international standard for colistin. Bull World Health Organ (1973) 1.38
Clinical diagnosis of malaria: can the patients help us improve? Trans R Soc Trop Med Hyg (1996) 1.37
Rough determination of the cost-benefit balance point of sanitation programmes. Bull World Health Organ (1976) 1.37
Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species. J Clin Microbiol (1996) 1.35
Synergism of benflumetol and artemether in Plasmodium falciparum. Am J Trop Med Hyg (1999) 1.33
The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care (1983) 1.32
Drug-resistant malaria--occurrence, control, and surveillance. Bull World Health Organ (1980) 1.32
Mefloquine concentration profiles during prophylactic dose regimens. Wien Klin Wochenschr (2000) 1.31
Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology (1994) 1.29
[Evaluation of the Vidas system for the serological diagnosis of toxoplasmosis]. Ann Biol Clin (Paris) (1993) 1.29
Single dose pharmacokinetics of oral artemether in healthy Malaysian volunteers. Br J Clin Pharmacol (1997) 1.28
In vitro response of chloroquine-resistant Plasmodium falciparum to mefloquine. Bull World Health Organ (1979) 1.28
Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand. Acta Trop (2002) 1.28
Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. Trans R Soc Trop Med Hyg (2003) 1.28
Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Aust N Z J Public Health (1998) 1.26
High-frequency jet ventilation in the early management of respiratory distress syndrome is associated with a greater risk for adverse outcomes. Pediatrics (1996) 1.26
Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am J Trop Med Hyg (1996) 1.26
Apoptosis related to chloroquine sensitivity of the human malaria parasite Plasmodium falciparum. Trans R Soc Trop Med Hyg (1998) 1.24
In vitro activity of quinolines against Plasmodium falciparum in Gabon. Acta Trop (2004) 1.22
Fluorescent antibody test in amebiasis. Clinical applications. Am J Trop Med Hyg (1972) 1.22
Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther (2001) 1.21
Chemokines in host-protozoan-parasite interactions. Trends Parasitol (2001) 1.20
Fatty acid synthesis in Escherichia coli. Biochem J (1967) 1.20
Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species. J Clin Microbiol (2001) 1.20
A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. Bull World Health Organ (1987) 1.19
Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso. J Clin Microbiol (1993) 1.18
[Detection of Toxoplasma gondii by "Polymerase Chain Reaction" (PCR) technique in AIDS infected patients using the repetitive sequence TGR1E]. Pathol Biol (Paris) (1992) 1.18
Evaluation of Wuchereria bancrofti infection in Culex pipiens fatigans in Rangoon, Burma. Bull World Health Organ (1967) 1.17
Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. Trans R Soc Trop Med Hyg (1995) 1.16
Immunoblot analysis demonstrates that the large and small forms of hepatitis delta virus antigen have different C-terminal amino acid sequences. J Gen Virol (1992) 1.16
Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers. Br J Clin Pharmacol (1989) 1.15
Human monkeypox: confusion with chickenpox. Acta Trop (1988) 1.15
Human monkeypox: secondary attack rates. Bull World Health Organ (1988) 1.15
Proceedings: A study of the effectiveness, toxicity, and bile salt kinetics of chenodeoxycholic acid in the treatment of human gallstones. Gut (1973) 1.14
Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum. Infect Immun (1990) 1.14
Prognosis of functional recovery 1 year after hip fracture: typical patient profiles through cluster analysis. J Gerontol A Biol Sci Med Sci (2000) 1.14
[Improvement of the immunofluorescence technic by the use of counter-dyes. Application to toxoplasmas]. Presse Med (1966) 1.14
TeleBAT: mobile telemedicine for the Brain Attack Team. J Stroke Cerebrovasc Dis (2007) 1.13
Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials. Trop Med Parasitol (1994) 1.12
Can GP input into discharge planning result in better outcomes for the frail aged: results from a randomized controlled trial. Fam Pract (1999) 1.12
Plasmodium falciparum growth inhibition by human platelets in vitro. Parasitology (1989) 1.11
[Immunofluorescence in the serodiagnosis of experimental and spontaneous human malaria. (Apropos of 39 cases)]. Bull Soc Pathol Exot Filiales (1966) 1.11
The effects of temperature on the composition and physical properties of the lipids of Pseudomonas fluorescens. Biochem J (1971) 1.11
Determination of a new antimalarial drug, benflumetol, in blood plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl (1996) 1.10
Plasmodium falciparum and P. malariae epidemiology in a West African village. Bull World Health Organ (1991) 1.10
[Rapid identification of sanguicolous parasites by staining with acridine orange and fluorescence microscopy]. Bull Soc Pathol Exot Filiales (1967) 1.10
Initial experience with transvaginal incisional hernia repair. Hernia (2009) 1.09
Statistical considerations in serological surveys of population with particular reference to malaria. J Trop Med Hyg (1974) 1.09
A DNA fingerprinting method for individual characterization of Toxoplasma gondii strains: combination with isoenzymatic characters for determination of linkage groups. Parasitol Res (1995) 1.08
Auxacolor, a new commercial system for yeast identification: evaluation of 182 strains comparatively with ID 32C. Ann Biol Clin (Paris) (1995) 1.08
Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand. Antimicrob Agents Chemother (2001) 1.08
In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance. Am J Trop Med Hyg (2001) 1.07
A new set of primers for the detection of Toxoplasma gondii in amniotic fluid using polymerase chain reaction. FEMS Microbiol Lett (1996) 1.07
The relevance of research to the global antimalaria programme. Bull World Health Organ (1977) 1.07
Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluid. Eur J Clin Microbiol Infect Dis (1996) 1.06
Central nervous system lymphosarcoma in the dog. J Am Vet Med Assoc (1984) 1.06
Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire. Trop Geogr Med (1988) 1.06
Intramuscular chloroquine in children. Lancet (1984) 1.05
Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. Antimicrob Agents Chemother (2001) 1.05
Epidemiology of Plasmodium falciparum in a rice field and a savanna area in Burkina Faso: seasonal fluctuations of gametocytaemia and malarial infectivity. Ann Trop Med Parasitol (1991) 1.05
Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 2. The impact of chloroquine used as a chemosuppressant on the immune status of the population. Bull World Health Organ (1982) 1.05
In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob Agents Chemother (2002) 1.04